Related Experiment Video
Updated: Dec 31, 2025

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
Expression and function of long non-coding RNA LINC01420 in thyroid cancer
Jin-Zhu Luo1, Lu Qin2, Ling-Jie Zhang3
1Department of Clinical Laboratory, Jingzhou Central Hospital, The Second Clinical Medical College, Yangtze University, Jingzhou, Hubei 434020, P.R. China.
Abstract:
The Human Genome Project revealed that >90% of the human genome was found to transcribe non-coding RNAs, including micro RNAs and long non-coding RNAs (lncRNAs). lncRNAs have been identified to play a crucial role in cancer progression. Thyroid cancer (TC) is a common type of endocrine cancer; however, the functional roles of lncRNAs in TC have yet to be fully elucidated. The present study investigated whether LINC01420 was upregulated in TC tissues, compared with normal thyroid tissues, and the results suggested that LINC01420 may play a regulatory role in TC. Bioinformatics analysis demonstrated that LINC01420 was associated with translation, rRNA processing, mRNA splicing, regulation of transcription, DNA repair and double-strand break repair. Furthermore, the exact role of LINC01420 in TC was explored by performing a loss-of-function assay, which revealed that the knockdown of LINC01420 inhibited TC cell proliferation and cell cycle progression. The findings of the present study provide a novel insight into the molecular mechanisms underlying TC development. Moreover, they suggest that LINC01420 may serve as a potential therapeutic target for the treatment of TC, and that increased LINC01420 expression levels show potential as a prognostic marker for the disease.
Insights
Long non-coding RNAs (lncRNAs) are key in cancer. This study shows LINC01420 is upregulated in thyroid cancer, inhibiting cell proliferation and progression, suggesting it as a therapeutic target.
Area of Science:
- Genomics
- Molecular Biology
- Oncology
Background:
- The human genome extensively transcribes non-coding RNAs, including long non-coding RNAs (lncRNAs).
- lncRNAs are implicated in various cancer progressions.
- The specific roles of lncRNAs in thyroid cancer (TC) remain largely unknown.
Purpose of the Study:
- To investigate the expression and function of LINC01420 in thyroid cancer.
- To explore the potential of LINC01420 as a diagnostic or therapeutic target in TC.
Main Methods:
- Comparative analysis of LINC01420 expression in TC tissues versus normal thyroid tissues.
- Bioinformatics analysis to predict LINC01420's molecular functions.
- Loss-of-function assays (e.g., knockdown) to assess LINC01420's impact on TC cell behavior.
Main Results:
- LINC01420 was found to be upregulated in thyroid cancer tissues.
- Bioinformatics analysis linked LINC01420 to critical cellular processes like translation, RNA processing, and DNA repair.
- Knockdown of LINC01420 significantly inhibited thyroid cancer cell proliferation and cell cycle progression.
Conclusions:
- LINC01420 plays a regulatory role in thyroid cancer development.
- LINC01420 may serve as a potential therapeutic target for thyroid cancer.
- Elevated LINC01420 expression levels show promise as a prognostic marker for TC.
Related Concept Videos
lncRNA - Long Non-coding RNAs
lncRNA - Long Non-coding RNAs
Non-LTR Retrotransposons
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
MicroRNAs
MicroRNAs
